Table 1 |
|||||
|
Characterization of sorafenib-incorporated nanoparticles |
|||||
|
Polymer/drug (mg/mg) |
Drug contents (%, w/w) |
Loading efficiency (%, w/w) |
Particle size (nm) |
Zeta potential (mV) |
|
|
Theoretical |
Experimental |
||||
|
|
|||||
|
40:0 |
- |
- |
- |
46 ± 1.12 |
-36.4 ± 3.1 |
|
40:2 |
4.76 |
1.23 |
25.84 |
63 ± 0.58 |
-35.5 ± 2.2 |
|
40:5 |
11.11 |
4.36 |
39.24 |
133 ± 0.58 |
-36.0 ± 1.1 |
|
40:7 |
14.89 |
5.26 |
35.33 |
181 ± 1.15 |
-35.8 ± 0.9 |
|
|
|||||
|
Kim et al. Nanoscale Research Letters 2012 7:91 doi:10.1186/1556-276X-7-91 |
|||||